Gilead, Aelix ally to trial HIV-suppressing combination

Gilead, Aelix ally to trial HIV-suppressing combination

Source: 
Fierce Biotech
snippet: 

Gilead has teamed up with Aelix Therapeutics to trial a combination designed to free people with HIV from the need to take antiretroviral drugs. The planned clinical trial will test Gilead’s TLR7 agonist in combination with Aelix’s T-cell vaccine.